McKesson Corporation (MCK)
Market Cap | 75.86B |
Revenue (ttm) | 308.95B |
Net Income (ttm) | 3.00B |
Shares Out | 129.71M |
EPS (ttm) | 22.39 |
PE Ratio | 26.12 |
Forward PE | 18.25 |
Dividend | $2.48 (0.42%) |
Ex-Dividend Date | Jun 3, 2024 |
Volume | 543,524 |
Open | 585.74 |
Previous Close | 586.34 |
Day's Range | 575.55 - 586.13 |
52-Week Range | 395.30 - 612.17 |
Beta | 0.47 |
Analysts | Strong Buy |
Price Target | 589.79 (+0.85%) |
Earnings Date | Aug 7, 2024 |
About MCK
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty ... [Read more]
Financial Performance
In 2023, McKesson's revenue was $308.95 billion, an increase of 11.65% compared to the previous year's $276.71 billion. Earnings were $3.00 billion, a decrease of -15.67%.
Financial StatementsAnalyst Forecast
According to 14 analysts, the average rating for MCK stock is "Strong Buy." The 12-month stock price forecast is $589.79, which is an increase of 0.85% from the latest price.
News
![](https://cdn.snapi.dev/images/v1/o/9/press1-2507656.jpg)
McKesson Releases Fiscal Year 2024 Impact Report
IRVING, Texas--(BUSINESS WIRE)--McKesson released its FY24 Impact Report, showcasing the company's ongoing commitment to its purpose of Advancing Health Outcomes for All®.
![](https://cdn.snapi.dev/images/v1/x/h/conf6-2498545.jpg)
McKesson Corporation Announces First Quarter Fiscal 2025 Earnings Release Date
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2025 financial results after market close on Wednesday, August 7, 2024. The company will host a l...
![](https://cdn.snapi.dev/images/v1/n/n/press9-2497331.jpg)
McKesson ideaShare Ignites and Inspires Independent Community Pharmacies
IRVING, Texas--(BUSINESS WIRE)--McKesson ideaShare hosted nearly 2,700 attendees including independent pharmacy owners and their staff in New Orleans.
![](https://cdn.snapi.dev/images/v1/i/7/press1-2493767.jpg)
Outcomes® Showcased at McKesson ideaShare 2024
NEW ORLEANS--(BUSINESS WIRE)--Outcomes, a leader in integrated pharmacy workflow and patient engagement solutions, announced that it will feature a new prescription counting solution, Pill Count, at M...
![](https://cdn.snapi.dev/images/v1/3/z/wall-st-3jpgfunccoverq70width7-2474035.jpg)
McKesson is a Growing Giant
McKesson Corporation (MCK) is poised to grow due to an aging population and expanding Type 2 diabetes treatments.
![](https://cdn.snapi.dev/images/v1/z/x/press11-2458730.jpg)
McKesson's Board of Directors Elects Deborah Dunsire as New Director
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced today that the McKesson board of directors has elected Dr. Deborah Dunsire as a director and member of the Compensation and T...
![](https://cdn.snapi.dev/images/v1/m/i/drugs14-2416766.jpg)
McKesson misses quarterly estimates as US pharmaceuticals segment weighs
McKesson Corp reported weaker-than-expected quarterly revenue and profit on Tuesday due to slump in demand for the company's branded and specialty drugs that dragged sales in its U.S. pharmaceutical s...
![](https://cdn.snapi.dev/images/v1/1/u/press16-2416286.jpg)
McKesson Corporation Reports Fiscal 2024 Fourth Quarter and Full Year Results
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2024 fourth quarter financial results. Results can be accessed on McKesson's Investor Relations website at inve...
![](https://cdn.snapi.dev/images/v1/b/z/press5-2387878.jpg)
McKesson Corporation Declares Quarterly Dividend
IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 62 cents per share of common stock. The dividend will be payable on J...
![](https://cdn.snapi.dev/images/v1/a/s/press3-2352125.jpg)
McKesson Launches Project Oasis to Address Pharmacy Deserts in Underserved Communities
IRVING, Texas--(BUSINESS WIRE)--McKesson launches Project Oasis, a new initiative aimed at advancing health equity for at-risk populations in underserved communities.
![](https://cdn.snapi.dev/images/v1/s/q/conf17-2344881.jpg)
McKesson Corporation Announces Fourth Quarter Fiscal 2024 Earnings Release Date
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its fourth quarter and full year fiscal 2024 financial results after market close on Tuesday, May 7, 2024. The company wil...
![](https://cdn.snapi.dev/images/v1/q/p/dzrzsy5yu5johnq4krrenmigf4-2342252.jpg)
Rite Aid reaches bankruptcy settlement with lenders, DOJ, McKesson
Pharmacy chain Rite Aid has reached a settlement with its lenders, the U.S. Department of Justice, and drug supplier McKesson Corp , clearing a path for Rite Aid to complete its bankruptcy case by lat...
![](https://cdn.snapi.dev/images/v1/k/p/press12-2324423.jpg)
McKesson Invites Community Pharmacists to Push the Industry Forward, Together
IRVING, Texas--(BUSINESS WIRE)--Register for McKesson ideaShare, a premier community pharmacy annual education and networking event, in New Orleans from June 23-26, 2024.
![](https://cdn.snapi.dev/images/v1/h/a/press20-2267123.jpg)
McKesson's Practice Insights Designated as a 2024 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services
IRVING, Texas--(BUSINESS WIRE)--McKesson received approval from CMS to participate in the Merit-based Incentive Payment System as a Qualified Clinical Data Registry for the 8th year.
![](https://cdn.snapi.dev/images/v1/7/r/yh7k6qfeufngzmxoiukbkdw6je-2265950.jpg)
McKesson raises annual profit forecast on strong demand for specialty medicines
U.S.-based drug distributor McKesson raised its annual profit forecast on Wednesday, banking on strong demand for specialty medicines.
![](https://cdn.snapi.dev/images/v1/e/0/press17-2265598.jpg)
McKesson Corporation Reports Fiscal 2024 Third Quarter Results and Raises Full Year Guidance
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2024 third quarter financial results. Results can be accessed on McKesson's Investor Relations website at inves...
![](https://cdn.snapi.dev/images/v1/h/o/im-735118size1777777777777778width800-2230995.jpg)
Charts turn bullish on health-care stocks as sector takes early lead in 2024
Chart-watchers are growing increasingly bullish on health-care stocks now that they have become the best-performing sector of the S&P 500 so far in 2024, according to Dow Jones Market Data. Analysts h...
![](https://cdn.snapi.dev/images/v1/3/d/drugs44-2227975.jpg)
US drug retailer McKesson seeks buyers for Canada's Rexall Pharmacy -source
McKesson Corp is planning to sell Canadian drugstore chain Rexall Pharmacy Group, a source familiar with the process told Reuters on Friday, seven years after the U.S. drug distributor bought the busi...
![](https://cdn.snapi.dev/images/v1/i/m/conf11-2222126.jpg)
McKesson to Present at the 42nd Annual J.P. Morgan Healthcare Conference
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will present at the 42nd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco today at 9:45 AM PT ...
![](https://cdn.snapi.dev/images/v1/v/u/conf5-2209472.jpg)
McKesson Corporation Announces Third Quarter Fiscal 2024 Earnings Release Date and Participation in January Conference
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2024 financial results after market close on Wednesday, February 7, 2024. The company will host a...
![](https://cdn.snapi.dev/images/v1/x/v/press13-2154423.jpg)
Edifecs Appoints Former McKesson Leader, Stephen Ayers, as Chief Financial Officer
BELLEVUE, Wash.--(BUSINESS WIRE)--Edifecs, Inc., a global health information technology solutions company, announced today the addition of Stephen Ayers to its leadership team as chief financial offic...
![](https://cdn.snapi.dev/images/v1/w/1/drugs19-2134719.jpg)
McKesson lifts annual profit forecast after strong quarterly results
Drug distributor McKesson Corp on Wednesday raised its annual profit forecast, banking on strong demand for specialty medicines.
![](https://cdn.snapi.dev/images/v1/w/9/press7-2134285.jpg)
McKesson Corporation Reports Fiscal 2024 Second Quarter Results and Raises Full Year Guidance
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2024 second quarter financial results. Results can be accessed on McKesson's Investor Relations website at inve...
![](https://cdn.snapi.dev/images/v1/d/2/tech-daily-ztymiqecyh4-unsplash-2-7-2113415.jpg)
McKesson Aims For The $500 Milestone After Shattering Previous Record Highs And Outperforming The S&P 500! - McKesson (NYSE:MCK)
McKesson Corp's MCK impressive performance stands out amidst a decline in the S&P 500 index.